Healthcare provider profile · identity verified

David Bostanjian, M.D.

General Practice · GLENDALE, CA · NPI 1639399280

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	547	72
Atorvastatin Calcium	Atorvastatin Calcium	488	59
Rosuvastatin Calcium	Rosuvastatin Calcium	342	42
Levothyroxine Sodium	Levothyroxine Sodium	338	34
Gabapentin	Gabapentin	337	51
Losartan Potassium	Losartan Potassium	326	43
Ibuprofen	Ibuprofen	323	57
Tamsulosin Hcl	Tamsulosin Hcl	312	40
Omeprazole	Omeprazole	303	50
Metformin Hcl	Metformin Hcl	291	35
Escitalopram Oxalate	Escitalopram Oxalate	238	31
Metoprolol Succinate	Metoprolol Succinate	207	31
Donepezil Hcl	Donepezil Hcl	188	23
Clonidine Hcl	Clonidine Hcl	186	30
Meclizine Hcl	Meclizine Hcl	170	37
Diclofenac Sodium	Diclofenac Sodium	167	36
Metoprolol Tartrate	Metoprolol Tartrate	154	19
Alendronate Sodium	Alendronate Sodium	134	16
Celecoxib	Celecoxib	124	19
Nebivolol Hcl	Nebivolol Hcl	119	13
Clopidogrel	Clopidogrel Bisulfate	117	15
Ezetimibe	Ezetimibe	117	15
Dexlansoprazole Dr	Dexlansoprazole	115	19
Glimepiride	Glimepiride	113	14
Carvedilol	Carvedilol	108	16
Lisinopril	Lisinopril	108	16
Allopurinol	Allopurinol	104	13
Buspirone Hcl	Buspirone Hcl	102	19
Dutasteride	Dutasteride	102	18
Olmesartan Medoxomil	Olmesartan Medoxomil	102	11
Vascepa	Icosapent Ethyl	99	14
Enalapril Maleate	Enalapril Maleate	96	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	95	26
Janumet	Sitagliptin Phos/Metformin Hcl	95	12
Simvastatin	Simvastatin	95	13
Furosemide	Furosemide	87	17
Montelukast Sodium	Montelukast Sodium	84	19
Potassium Chloride	Potassium Chloride	79	15
Famotidine	Famotidine	78	13
Clonidine	Clonidine	77	12
Fenofibrate	Fenofibrate	77	17
Meloxicam	Meloxicam	77	16
Azithromycin	Azithromycin	76	54
Benazepril Hcl	Benazepril Hcl	69	suppressed
Linzess	Linaclotide	69	16
Pregabalin	Pregabalin	68	suppressed
Trazodone Hcl	Trazodone Hcl	68	14
Valsartan	Valsartan	59	suppressed
Icosapent Ethyl	Icosapent Ethyl	57	11
Nifedipine Er	Nifedipine	57	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	56	suppressed
Eliquis	Apixaban	54	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	54	suppressed
Ozempic	Semaglutide	54	suppressed
Finasteride	Finasteride	53	suppressed
Atenolol	Atenolol	50	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	45	suppressed
Paroxetine Hcl	Paroxetine Hcl	42	suppressed
Cilostazol	Cilostazol	41	suppressed
Farxiga	Dapagliflozin Propanediol	41	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	41	34
Sumatriptan Succinate	Sumatriptan Succinate	40	suppressed
Tramadol Hcl	Tramadol Hcl	37	suppressed
Clobetasol Propionate	Clobetasol Propionate	36	11
Fluticasone Propionate	Fluticasone Propionate	35	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	35	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	33	suppressed
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	32	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	31	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	30	suppressed
Entresto	Sacubitril/Valsartan	30	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	29	suppressed
Irbesartan	Irbesartan	29	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	29	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	22
Ondansetron Hcl	Ondansetron Hcl	26	12
Oseltamivir Phosphate	Oseltamivir Phosphate	26	24
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Levofloxacin	Levofloxacin	24	23
Trintellix	Vortioxetine Hydrobromide	23	suppressed
Glipizide	Glipizide	22	suppressed
Ibu	Ibuprofen	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Sertraline Hcl	Sertraline Hcl	21	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	20	suppressed
Baclofen	Baclofen	20	14
Diclofenac Epolamine	Diclofenac Epolamine	20	suppressed
Diclofenac Potassium	Diclofenac Potassium	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Jardiance	Empagliflozin	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	16
Mesalamine	Mesalamine	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Naproxen	Naproxen	14	suppressed
Omeprazole-Sodium Bicarbonate	Omeprazole/Sodium Bicarbonate	14	suppressed
Cephalexin	Cephalexin	13	suppressed
Dutasteride-Tamsulosin	Dutasteride/Tamsulosin Hcl	13	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Synjardy	Empagliflozin/Metformin Hcl	13	suppressed
Alcohol Swab	Alcohol Antiseptic Pads	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	12	suppressed
Pravastatin Sodium	Pravastatin Sodium	12	suppressed
Topiramate	Topiramate	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Betamethasone Valerate	Betamethasone Valerate	11	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error